Intraoperative Course and Prognostic Significance of Endotoxin, Tumor Necrosis Factor-alpha and Interleukin-6 in Liver Transplant Recipients
Authors:
- Maria PrettenhoferMPMaria Prettenhofer
- Anna ZommerAZAnna Zommer
- Susanne HofbauerSHSusanne Hofbauer
- Peter GotzingerPGPeter Gotzinger
- Franz Xaver GnantFGFranz Xaver Gnant
- Reinhold RiggerRRReinhold Rigger
- 1 August 1991
- journal article
- Published by Elsevier in Immunobiology
- Vol. 182 (5) , 425-439
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- II. EVIDENCE THAT ANTIBODY THERAPY AGAINST TUMOR NECROSIS FACTOR-ALPHA AND LYMPHOTOXIN ENHANCES CARDIAC ALLOGRAFT SURVIVAL IN RATSTransplantation, 1990
- Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma.Journal of Experimental Medicine, 1989
- Plasma tumor necrosis factor and mortality in critically ill septic patientsCritical Care Medicine, 1989
- RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1989
- EVIDENCE OF INVOLVEMENT OF TUMOR NECROSIS FACTOR IN ADVERSE REACTIONS DURING TREATMENT OF KIDNEY ALLOGRAFT REJECTION WITH ANTITHYMOCYTE GLOBULINTransplantation, 1989
- SOLUBLE INTERLEUKIN-2 RECEPTOR LEVEL AS AN INDICATOR OF LIVER ALLOGRAFT REJECTIONTransplantation, 1989
- Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.Journal of Experimental Medicine, 1988
- Prevention of Death following One-Hour Occlusion of the Portal Vein in the RatEuropean Surgical Research, 1988
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.Journal of Experimental Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987